|
Subsequent Event (Details) (PDL BioPharma Inc [Member], USD $)
|
6 Months Ended | ||||
|---|---|---|---|---|---|
|
Aug. 14, 2012
|
Jun. 30, 2012
Acquired Revenues Receivable Option-1 [Member]
|
Jun. 30, 2012
Acquired Revenues Receivable Option-2 [Member]
|
Jun. 30, 2012
Termination of Contract [Member]
|
Jun. 30, 2012
Termination of Contract [Member]
Minimum [Member]
|
|
| Subsequent Event (Textual) [Abstract] | |||||
| Amount received under interim royalty contract | $ 1,750,000 | ||||
| Percentage of acquired royalty revenues (on Company Gross Revenue per month) | 3.00% | 5.00% | |||
| Acquired Revenues (value per month) | 112,257 | ||||
| Period duration for royalty revenue receivable | from August 1, 2012 toDecember 31, 2012 | from January 1, 2013 to August 31,2014 | |||
| Receipt of Investment from an investor other than PDL | 500,000 | ||||
| Early Termination Fee | $ 150,000 | ||||